Internal Medicine, Pulmonary Disease · Ann Arbor, MI
NPI
1104908011
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 E Medical Center Dr
Ann Arbor, MI, 48109
Phone (734) 936-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
1,246 services
Medicare patients, 2024
454
Average age 69
Drug cost, 2024
$2.7M
2,180 prescriptions
Company payments, 2024
$21.8
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Coffey was code 94010 (pulmonary function testing), 214 times for 196 patients. In total Michael J Coffey billed 1,246 services in 21 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Facility | 214 | 196 | $6.00 | $1,284 |
| 94729 Pulmonary Function Testing | Facility | 167 | 152 | $6.49 | $1,084 |
| 99214 Office E&M - Established | Facility | 144 | 99 | $73.27 | $11K |
| 94010 Pulmonary Function Testing | Office | 138 | 121 | $5.67 | $783 |
| 94729 Pulmonary Function Testing | Office | 110 | 94 | $6.32 | $696 |
| 99214 Office E&M - Established | Office | 98 | 81 | $71.79 | $7,036 |
| 99232 Hospital E&M - Subsequent | Facility | 65 | 26 | $63.19 | $4,108 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 54 | 47 | $13.12 | $708 |
| 99222 Hospital E&M - Initial | Facility | 51 | 44 | $103.44 | $5,275 |
| 94726 Pulmonary Function Testing | Facility | 28 | 28 | $9.14 | $256 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 27 | 26 | $12.62 | $341 |
| 99205 Office E&M - New | Facility | 24 | 24 | $142.24 | $3,414 |
| 99205 Office E&M - New | Office | 21 | 21 | $131.44 | $2,760 |
| 94060 Pulmonary Function Testing | Facility | 19 | 18 | $8.00 | $152 |
| 94618 Pulmonary Function Testing | Facility | 18 | 18 | $17.29 | $311 |
By year: 2022 $50K for 1,338 services; 2023 $52K for 1,398 services; 2024 $43K for 1,246 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Coffey prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 306 prescriptions and refills. In total Michael J Coffey wrote 2,180 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 306 | 354 | 97 | $12K |
| Montelukast Sodium Generic | 172 | 405 | 45 | $2,682 |
| Azithromycin Generic | 129 | 185 | 34 | $2,383 |
| Fluticasone Propionate Generic | 118 | 159 | 29 | $944 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 106 | 153 | 33 | $16K |
| Prednisone Generic | 92 | 141 | 45 | $503 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 75 | 99 | 16 | $60K |
| Dupixent Pen Dupilumab | 68 | 68 | Under 11 | $253K |
| Fasenra Pen Benralizumab | 65 | 107 | 11 | $359K |
| Incruse Ellipta Umeclidinium Bromide | 59 | 63 | 11 | $21K |
| Spiriva Respimat Tiotropium Bromide | 56 | 84 | 15 | $43K |
| Pirfenidone Generic | 55 | 55 | Under 11 | $98K |
| Ofev Nintedanib Esylate | 52 | 52 | Under 11 | $666K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 41 | 48 | Under 11 | $155 |
| Ventolin Hfa Albuterol Sulfate | 40 | 51 | 16 | $2,964 |
Brand drugs: 1,127 claims; generic drugs: 1,053 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michael J Coffey $21.8 ($21.8 in general payments such as food, travel and fees) from 1 company. The largest payer was Ironshore Pharmaceuticals Inc. with $21.8.
| Company | Payments | Amount |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 1 | $21.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.